Molecular modeling of inhibitors of human DNa methyltransferase with a crystal structure: Discovery of a novel dnmt1 inhibitor

Advances in Protein Chemistry and Structural Biology

Volumn 87, Issue , 2012, Pages 219-247

  Yoo, Jakyung ^a   Kim, Joo Hee ^b   Robertson, Keith D ^b   Medina Franco, José L ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Cancer; DNMT; Docking; Drug discovery; Epigenetics; Molecular dynamics; Pharmacophore modeling

Indexed keywords

EID: 84861164104     PISSN: 18761623     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-398312-1.00008-1     Document Type: Chapter

References (53)

1. C. Arce, B. Segura-Pacheco, E. Perez-Cardenas, L. Taja-Chayeb, M. Candelaria, and A. Dueñnas-Gonzalez Hydralazine target: from blood vessels to the epigenome J. Transl. Med. 4 2006 10
2. M. Bouvet, C. Debarnot, I. Imbert, B. Selisko, E.J. Snijder, and B. Canard In vitro reconstitution of SARS-Coronavirus mRNA cap methylation PLoS Pathog. 6 2010 e1000863
3. T. Caulfield, and J.L. Medina-Franco Molecular dynamics simulations of human DNA methyltransferase 3B with selective inhibitor nanaomycin A J. Struct. Biol. 176 2011 185 191
4. T.P. Chen, S. Hevi, F. Gay, N. Tsujimoto, T. He, and B.L. Zhang Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells Nat. Genet. 39 2007 391 396
5. X.D. Cheng, and R.M. Blumenthal Mammalian DNA methyltransferases: a structural perspective Structure 16 2008 341 350
6. A. Dueñas-González, P. García-López, L.A. Herrera, J.L. Medina-Franco, A. González-Fierro, and M. Candelaria The prince and the pauper. A tale of anticancer targeted agents Mol. Cancer 7 2008 82
7. D.A. Evans, and A.K. Bronowska Implications of fast-time scale dynamics of human DNA/RNA cytosine methyltransferases (DNMTs) for protein function Theor. Chem. Acc. 125 2010 407 418
8. T.E. Fandy, J.G. Herman, P. Kerns, A. Jiemjit, E.A. Sugar, and S.H. Choi Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies Blood 114 2009 2764 2773
9. E.R. Gilbert, and D. Liu Flavonoids influence epigenetic-modifying enzyme activity: structure-function relationships and the therapeutic potential for cancer Curr. Med. Chem. 17 2010 1756 1768
10. M.G. Goll, and T.H. Bestor Eukaryotic cytosine methyltransferases Annu. Rev. Biochem. 74 2005 481 514
11. A.T. Hauser, and M. Jung Targeting epigenetic mechanisms: potential of natural products in cancer chemoprevention Planta Med. 74 2008 1593 1601
12. A. Hernández-Campos, I. Velázquez-Martínez, R. Castillo, F. López-Vallejo, P. Jia, and Y. Yu Docking of protein kinase B inhibitors: implications in the structure-based optimization of a novel scaffold Chem. Biol. Drug Des. 76 2010 269 276
13. J.-P. Issa Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: dose, duration, and patient selection Nat. Clin. Pract. Oncol. 2 Suppl 1 2005 S24 S29
14. J.-P.J. Issa, and H.M. Kantarjian Targeting DNA methylation Clin. Cancer Res. 15 2009 3938 3946
15. J.P.J. Issa, H.M. Kantarjian, and P. Kirkpatrick Azacitidine Nat. Rev. Drug Discov. 4 2005 275 276
16. A. Jeltsch Beyond Watson and Crick: DNA methylation and molecular enzymology of DNA methyltransferases ChemBioChem 3 2002 274 293
17. D. Jia, R.Z. Jurkowska, X. Zhang, A. Jeltsch, and X. Cheng Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation Nature 449 2007 248 251
18. P.A. Jones, and S.B. Baylin The epigenomics of cancer Cell 128 2007 683 692
19. R.Z. Jurkowska, T.P. Jurkowski, and A. Jeltsch Structure and function of mammalian DNA methyltransferases ChemBioChem 12 2011 206 222
20. T.K. Kelly, D.D. De Carvalho, and P.A. Jones Epigenetic modifications as therapeutic targets Nat. Biotechnol. 28 2010 1069 1078
21. S. Klimasauskas, S. Kumar, R.J. Roberts, and X.D. Cheng Hhal methyltransferase flips its target base out of the DNA helix Cell 76 1994 357 369
22. D. Kuck, T. Caulfield, F. Lyko, and J.L. Medina-Franco Nanaomycin A selectively inhibits DNMT3B and reactivates silenced tumor suppressor genes in human cancer cells Mol. Cancer Ther. 9 2010 3015 3023
23. D. Kuck, N. Singh, F. Lyko, and J.L. Medina-Franco Novel and selective DNA methyltransferase inhibitors: docking-based virtual screening and experimental evaluation Bioorg. Med. Chem. 18 2010 822 829
24. S. Kumar, J.R. Horton, G.D. Jones, R.T. Walker, R.J. Roberts, and X. Cheng DNA containing 4′-thio-2′-deoxycytidine inhibits methylation by HhaI methyltransferase Nucleic Acids Res. 25 1997 2773 2783
25. J. Lan, S. Hua, X.N. He, and Y. Zhang DNA methyltransferases and methyl-binding proteins of mammals Acta Biochim. Biophys. Sin. 42 2010 243 252
26. Y. Li, and T.O. Tollefsbol Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components Curr. Med. Chem. 17 2010 2141 2151
27. LigPrep., version 2.2 2005 Schrödinger, LLC New York, NY
28. Z.F. Liu, S.J. Liu, Z.L. Xie, R.E. Pavlovicz, J. Wu, and P. Chen Modulation of DNA methylation by a sesquiterpene lactone parthenolide J. Pharmacol. Exp. Ther. 329 2009 505 514
29. F. López-Vallejo, T. Caulfield, K. Martínez-Mayorga, M.A. Giulianotti, A. Nefzi, and R.A. Houghten Integrating virtual screening and combinatorial chemistry for accelerated drug discovery Comb. Chem. High Throughput Screen. 14 2011 475 487
30. F. Lyko, and R. Brown DNA methyltransferase inhibitors and the development of epigenetic cancer therapies J. Natl. Cancer Inst. 97 2005 1498 1506
31. MacroModel, version 9.8 2010 Schrödinger, LLC New York, NY
32. J.L. Medina-Franco, and T. Caulfield Advances in the computational development of DNA methyltransferase inhibitors Drug Discovery Today 16 2011 418 425
33. J. Medina-Franco, F. López-Vallejo, D. Kuck, and F. Lyko Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach Mol. Diversity 15 2011 293 304
34. M. Milani, E. Mastrangelo, M. Bollati, B. Selisko, E. Decroly, and M. Bouvet Flaviviral methyltransferase/RNA interaction: structural basis for enzyme inhibition Antiviral Res. 83 2009 28 34
35. C.A. Miller, C.F. Gavin, J.A. White, R.R. Parrish, A. Honasoge, and C.R. Yancey Cortical DNA methylation maintains remote memory Nat. Neurosci. 13 2010 664 666
36. S.S. Palii, B.O. Van Emburgh, U.T. Sankpal, K.D. Brown, and K.D. Robertson DNA methylation inhibitor 5-aza-2′-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B Mol. Cell. Biol. 28 2008 752 771
37. M. Podvinec, S.P. Lim, T. Schmidt, M. Scarsi, D. Wen, and L.-S. Sonntag Novel inhibitors of dengue virus methyltransferase: discovery by in vitro-driven virtual screening on a desktop computer grid J. Med. Chem. 53 2010 1483 1495
38. A. Portela, and M. Esteller Epigenetic modifications and human disease Nat. Biotechnol. 28 2010 1057 1068
39. K.D. Robertson DNA methylation, methyltransferases, and cancer Oncogene 20 2001 3139 3155
40. N.K. Salam, R. Nuti, and W. Sherman Novel method for generating structure-based pharmacophores using energetic analysis J. Chem. Inf. Model. 49 2009 2356 2368
41. L. Schermelleh, F. Spada, H.P. Easwaran, K. Zolghadr, J.B. Margot, and M.C. Cardoso Trapped in action: direct visualization of DNA methyltransferase activity in living cells Nat. Methods 2 2005 751 756
42. D.S. Schrump, M.R. Fischette, D.M. Nguyen, M. Zhao, X.M. Li, and T.F. Kunst Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura Clin. Cancer Res. 12 2006 5777 5785
43. P. Siedlecki, R.G. Boy, T. Musch, B. Brueckner, S. Suhai, and F. Lyko Discovery of two novel, small-molecule inhibitors of DNA methylation J. Med. Chem. 49 2006 678 683
44. N. Singh, A. Dueñas-González, F. Lyko, and J.L. Medina-Franco Molecular modeling and dynamics studies of hydralazine with human DNA methyltransferase 1 ChemMedChem 4 2009 792 799
45. W. Sippl, and M. Jung DNA methyltransferase inhibitors W. Sippl, M. Jung, Epigenetic Targets in Drug Discovery 2009 Wiley-VCH Weinheim 163 183
46. J. Song, O. Rechkoblit, T.H. Bestor, and D.J. Patel Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation Science 331 2011 1036 1040
47. C. Stresemann, and F. Lyko Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine Int. J. Cancer 123 2008 8 13
48. G. Vilkaitis, E. Merkiene, S. Serva, E. Weinhold, and S. Klimasauskas The mechanism of DNA cytosine-5 methylation: kinetic and mutational dissection of HhaI methyltransferase J. Biol. Chem. 276 2001 20924 20934
49. T. Yokochi, and K.D. Robertson Preferential methylation of unmethylated DNA by mammalian de novo DNA methyltransferase Dnmt3a J. Biol. Chem. 277 2002 11735 11745
50. J. Yoo, and J.L. Medina-Franco Discovery and optimization of inhibitors of DNA methyltransferase as novel drugs for cancer therapy Dr., Rundfeldt Chris, Drug Development - A Case Study Based Insight into Modern Strategies 2011 InTech Croatia 978-953-307-257-9 Available at: http://www.intechopen.com/books/ drug-development-a-case-study-based-insight-into-modern-strategies/ discovery-and-optimization-of-inhibitors-of-dna-methyltransferase-as-novel- drugs-for-cancer-therapy
51. J. Yoo, and J.L. Medina-Franco Homology modeling, docking, and structure-based pharmacophore of inhibitors of DNA methyltransferase J. Comput.-Aided Mol. Des. 25 2011 555 567
52. J. Yoo, and J.L. Medina-Franco Trimethylaurintricarboxylic acid inhibits human DNA methyltransferase 1: insights from enzymatic and molecular modeling studies J. Mol. Model 18 2011 1583 1589
53. N.H. Zawia, D.K. Lahiri, and F. Cardozo-Pelaez Epigenetics, oxidative stress, and Alzheimer disease Free Radic. Biol. Med. 46 2009 1241 1249